Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospital de Clinicas de Porto Alegre
With
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Federal University of Health Science of Porto Alegre
Home Blood Pressure Monitoring (HBPM) and Pharmaceutical care have been proposed to improve therapeutic compliance and to guide treatment decisions, but their effects on BP control are still under debate.
This is a factorial randomized controlled trial including adult hypertensive patients under drug treatment but with office BP and 24h ABPM uncontrolled. Participants will be allocated to one of four groups: HBPM; HBPM and Pharmaceutical care; Pharmaceutical care; or control. All participants will receive usual care for high blood pressure. Participants will be followed for 60 days.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Office BP ≥140/90 mm Hg
24h ABPM hypertension BP ≥130/80 mm Hg
using at least one antihypertensive drug
You may not be if
BP ≥ 180 / 110 mmHg)
major cardiovascular events in the last six months
acute or chronic diseases limiting the capacity to understand and to participate in the trial
masked hypertension
white-coat hypertension
secondary hypertension
pregnancy
breastfeeding
concurrent participation in another trial
Clareo Health | Efficacy of Home Blood Pressure Monitoring (MONITOR Study)
